# H1-0

## Overview
The H1-0 gene encodes the H1.0 linker histone, a variant of the histone H1 family, which plays a pivotal role in chromatin structure and gene regulation. The H1.0 protein is categorized as a linker histone, characterized by its ability to bind to the nucleosome and facilitate the compaction of chromatin into higher-order structures. Unlike other histone variants, H1.0 is predominantly expressed in differentiated and non-dividing cells, where it contributes to the stabilization of condensed chromatin and influences gene expression by maintaining nucleosomal organization (Di2018H1.0; Kowalski2016Nuclear). The protein's structure includes a central globular domain and flexible terminal tails, which allow it to interact with DNA and various proteins, playing a role in processes such as nucleolar organization, DNA repair, and cell cycle control (Kowalski2016Nuclear; Kalashnikova2013Linker). Clinically, alterations in H1-0 expression are significant in cancer biology, where its downregulation is associated with tumor progression, and its re-expression is being explored as a therapeutic strategy (Morales2020Selective).

## Structure
The H1-0 gene encodes the H1.0 linker histone, a variant of the histone H1 family involved in chromatin structure. The protein consists of a central globular domain flanked by unstructured N-terminal and C-terminal tails (Kalashnikova2013Linker). The primary structure of H1.0 includes 194 amino acids, with a unique composition featuring fewer alanine residues and more serine, arginine, phenylalanine, isoleucine, and leucine compared to other H1 variants (Kowalski2016Nuclear).

The secondary structure of the globular domain is characterized by a winged helix fold, comprising three α helices and a small β strand (Lyubitelev2016Structure). This domain is crucial for binding to nucleosomal DNA, with specific sites interacting with the DNA backbone and strands (Kowalski2016Nuclear). The C-terminal domain is intrinsically disordered, allowing it to undergo disorder-to-order transitions upon binding to DNA and proteins, which is essential for chromatin condensation (Kowalski2016Nuclear).

Post-translational modifications, particularly phosphorylation, influence the structural conformation and function of H1.0, affecting chromatin compaction and gene expression (Kowalski2016Nuclear). The protein's ability to interact with a network of nucleolar proteins suggests a role in RNA metabolism and chromatin organization (Kalashnikova2013Linker).

## Function
Histone H1.0 is a linker histone variant that plays a crucial role in chromatin structure and gene regulation in healthy human cells. It is primarily expressed in differentiated and non-dividing cells, where it contributes to the formation and stabilization of condensed chromatin structures, influencing gene expression by maintaining nucleosomal and higher-order chromatin organization (Di2018H1.0; Kowalski2016Nuclear). H1.0 is involved in the regulation of chromatin structure and gene expression, acting as a specific regulator rather than a global one, and is known to repress more genes compared to other H1 variants (Di2018H1.0).

H1.0 is abundant in nucleoli-associated DNA domains and is involved in nucleolar organization, cell cycle control, DNA repair, cell senescence, and apoptosis (Di2018H1.0). It interacts with proteins involved in rRNA biogenesis and cellular transport, suggesting a role in mRNA splice site recognition (Di2018H1.0). The protein is also implicated in maintaining genome stability and regulating DNA replication and repair (Di2018H1.0). In fibroblasts, H1.0 modulates chromatin organization and cellular mechanical properties, affecting the transcription of stress-responsive genes (Hu2024Histone).

## Clinical Significance
Alterations in the expression of the H1-0 gene, which encodes the H1.0 linker histone, have significant clinical implications, particularly in cancer. H1.0 is identified as a tumor-suppressive factor that inhibits cancer cell self-renewal across various cancer types. Its expression is often downregulated in self-renewing cancer cells, contributing to tumor maintenance and disease relapse. The re-expression of H1.0 can be induced by Quisinostat, a histone deacetylase inhibitor, which effectively inhibits cancer cell self-renewal and tumor maintenance without affecting normal stem cell function (Morales2020Selective).

In cancer treatment, the Quisinostat-H1.0 axis plays a crucial role in preventing disease relapse by maintaining a differentiated, non-proliferative state in surviving cancer cells. This approach is particularly effective in cancer cells resistant to targeted therapies, such as EGFR tyrosine kinase inhibitors in non-small cell lung cancer and the anti-HER2 antibody Trastuzumab in breast cancer (Morales2020Selective). The clinical efficacy of Quisinostat is attributed to its ability to restore high levels of H1.0, which impairs cancer cell self-renewal by downregulating oncogenic pathways like TGFβ signaling and epithelial-to-mesenchymal transition (Morales2020Selective).

## Interactions
Histone H1.0, a variant of the linker histone family, is involved in numerous interactions with proteins and nucleic acids, playing a significant role in chromatin organization and gene regulation. H1.0 interacts with over 100 proteins, including components of ribosomal subunits and nuclear ribonucleoproteins, which can suppress gene transcription (Chikhirzhina2020The). It is a central component of a large network of protein-protein interactions within the nucleolus, interacting with proteins involved in pre-mRNA splicing, rRNA biogenesis, translation, and cellular transport (Kalashnikova2013Linker). 

The C-terminal domain (CTD) of H1.0 is crucial for many of these interactions, including those with DNA repair proteins like Ku70 and Ku86, which aid in chromatin compaction and protection of damaged regions (Chikhirzhina2020The; Kalashnikova2016Linker). H1.0 also interacts with high mobility group proteins, such as HMGN and HMGB, affecting chromatin compaction and transcription (Chikhirzhina2020The). 

In the nucleolus, H1.0 binds to proteins like U2AF65, SF2/ASF, and the FACT complex, suggesting a regulatory role in nucleolar activities and RNA metabolism (Kowalski2016Nuclear; Kalashnikova2013Linker). These interactions highlight the multifaceted roles of H1.0 in gene regulation and chromatin dynamics.


## References


[1. (Chikhirzhina2020The) E. V. Chikhirzhina, T. Yu. Starkova, and A. M. Polyanichko. The role of linker histones in chromatin structural organization. 2. interaction with dna and nuclear proteins. Biophysics, 65(2):202–212, March 2020. URL: http://dx.doi.org/10.1134/S0006350920020049, doi:10.1134/s0006350920020049. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1134/S0006350920020049)

[2. (Di2018H1.0) Carlo Maria Di Liegro, Gabriella Schiera, and Italia Di Liegro. H1.0 linker histone as an epigenetic regulator of cell proliferation and differentiation. Genes, 9(6):310, June 2018. URL: http://dx.doi.org/10.3390/genes9060310, doi:10.3390/genes9060310. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes9060310)

[3. (Kowalski2016Nuclear) Andrzej Kowalski. Nuclear and nucleolar activity of linker histone variant h1.0. Cellular &amp; Molecular Biology Letters, August 2016. URL: http://dx.doi.org/10.1186/s11658-016-0014-0, doi:10.1186/s11658-016-0014-0. This article has 7 citations.](https://doi.org/10.1186/s11658-016-0014-0)

[4. (Hu2024Histone) Shuaishuai Hu, Douglas J. Chapski, Natalie D. Gehred, Todd H. Kimball, Tatiana Gromova, Angelina Flores, Amy C. Rowat, Junjie Chen, René R. Sevag Packard, Emily Olszewski, Jennifer Davis, Christoph D. Rau, Timothy A. McKinsey, Manuel Rosa-Garrido, and Thomas M. Vondriska. Histone h1.0 couples cellular mechanical behaviors to chromatin structure. Nature Cardiovascular Research, 3(4):441–459, April 2024. URL: http://dx.doi.org/10.1038/s44161-024-00460-w, doi:10.1038/s44161-024-00460-w. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s44161-024-00460-w)

[5. (Lyubitelev2016Structure) A. V. Lyubitelev, D. V. Nikitin, A. K. Shaytan, V. M. Studitsky, and M. P. Kirpichnikov. Structure and functions of linker histones. Biochemistry (Moscow), 81(3):213–223, March 2016. URL: http://dx.doi.org/10.1134/S0006297916030032, doi:10.1134/s0006297916030032. This article has 21 citations.](https://doi.org/10.1134/S0006297916030032)

[6. (Kalashnikova2016Linker) Anna A. Kalashnikova, Ryan A. Rogge, and Jeffrey C. Hansen. Linker histone h1 and protein–protein interactions. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 1859(3):455–461, March 2016. URL: http://dx.doi.org/10.1016/j.bbagrm.2015.10.004, doi:10.1016/j.bbagrm.2015.10.004. This article has 60 citations.](https://doi.org/10.1016/j.bbagrm.2015.10.004)

[7. (Morales2020Selective) Cristina Morales Torres, Mary Y. Wu, Sebastijan Hobor, Elanor N. Wainwright, Matthew J. Martin, Harshil Patel, William Grey, Eva Grönroos, Steven Howell, Joana Carvalho, Ambrosius P. Snijders, Michael Bustin, Dominique Bonnet, Paul D. Smith, Charles Swanton, Michael Howell, and Paola Scaffidi. Selective inhibition of cancer cell self-renewal through a quisinostat-histone h1.0 axis. Nature Communications, April 2020. URL: http://dx.doi.org/10.1038/s41467-020-15615-z, doi:10.1038/s41467-020-15615-z. This article has 28 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-020-15615-z)

[8. (Kalashnikova2013Linker) Anna A. Kalashnikova, Duane D. Winkler, Steven J. McBryant, Ryan K. Henderson, Jacob A. Herman, Jennifer G. DeLuca, Karolin Luger, Jessica E. Prenni, and Jeffrey C. Hansen. Linker histone h1.0 interacts with an extensive network of proteins found in the nucleolus. Nucleic Acids Research, 41(7):4026–4035, February 2013. URL: http://dx.doi.org/10.1093/nar/gkt104, doi:10.1093/nar/gkt104. This article has 78 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkt104)